Cargando…
The complex clinical response to selective serotonin reuptake inhibitors in depression: a network perspective
The clinical response to selective serotonin reuptake inhibitors (SSRIs) in depression takes weeks to be fully developed and is still not entirely understood. This study aimed to determine the direct and indirect effects of SSRIs relative to a placebo control condition on clinical symptoms of depres...
Autores principales: | Boschloo, Lynn, Hieronymus, Fredrik, Lisinski, Alexander, Cuijpers, Pim, Eriksson, Elias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867733/ https://www.ncbi.nlm.nih.gov/pubmed/36681669 http://dx.doi.org/10.1038/s41398-022-02285-2 |
Ejemplares similares
-
Impact of chosen cutoff on response rate differences between selective serotonin reuptake inhibitors and placebo
por: Lisinski, Alexander, et al.
Publicado: (2022) -
Consistent superiority of selective serotonin reuptake inhibitors over placebo in reducing depressed mood in patients with major depression
por: Hieronymus, F, et al.
Publicado: (2016) -
Selective serotonin reuptake inhibitors, and serotonin and norepinephrine reuptake inhibitors for anxiety, obsessive-compulsive, and stress disorders: A 3-level network meta-analysis
por: Gosmann, Natan Pereira, et al.
Publicado: (2021) -
Commentary: “Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression”
por: Fried, Eiko I., et al.
Publicado: (2015) -
Selective serotonin reuptake inhibitors and Alzheimer’s disease
por: Mdawar, Bernadette, et al.
Publicado: (2019)